Rohto Pharmaceutical

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (June 2014) (Learn how and when to remove this message) This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (June 2014) (Learn how and when to remove this message) (Learn how and when to remove this message)

Rohto Pharmaceutical Co., Ltd.

Native name	ロート製薬株式会社
Romanized name	Rōto Seiyaku kabushiki gaisha
Company type	Public KK
Traded as	TYO: 4527
Industry	FMCG Pharmaceuticals
Founded	Higashinari-ku, Osaka, Japan (September 15, 1949 (1949-09-15), to reorganize "Shintendo, Yasutami Yamada pharmaceutical Company")
Founder	Yasutami Yamada
Headquarters	Ikuno-ku, Osaka, Japan
Key people	Kunio Yamada (chair and CEO, great-grandson of the founder) Toshiaki Yoshino (president and COO)
Revenue	¥120,292 million (FY 2011)[* 1] ¥115,472 million (FY 2010)
Operating income	¥13,624 million (FY 2011)[* 1] ¥13,105 million (FY 2010)
Net income	¥8,184 million (FY 2011)[* 1] ¥7,966 million (FY 2010)
Total assets	¥136,008 million (FY 2011)[* 1] ¥126,472 million (FY 2010)
Total equity	¥83,627 million (FY 2011)[* 1] ¥77,911 million (FY 2010)
Number of employees	5,518 (March 31, 2013)
Subsidiaries	Mentholatum Rohto Advanced Research Hong Kong Ltd
Website	www.rohto.co.jp/global/
Footnotes / references ^ a b c d e "Financial Results for the Fiscal Year Ended March 31, 2012" (PDF). Rohto Pharmaceutical Co., Ltd. May 11, 2012. Retrieved November 12, 2012.

Rohto Pharmaceutical Co., Ltd. (ロート製薬株式会社, Rōto Seiyaku Kabushiki-gaisha) is a multinational corporation in fast-moving consumer goods and pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan. with revenues steadily increasing from ¥95,619 million in 2006 to ¥120,292 million in 2011. Skin care contributes to 61.3% of the revenues, while Eye Care contributes to 21% of their sales.